IN2012DN06416A - - Google Patents

Info

Publication number: IN2012DN06416A
Authority: IN; India

Application number

Inventor

P Pujara Chetan

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-22

Filing date

2012-07-20

Publication date

2015-10-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43743470&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN06416(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-07-20 Application filed by Allergan Inc filed Critical Allergan Inc

2015-10-09 Publication of IN2012DN06416A publication Critical patent/IN2012DN06416A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

IN6416DEN2012 2009-12-22 2012-07-20 IN2012DN06416A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28893609P	2009-12-22	2009-12-22
US36174910P	2010-07-06	2010-07-06
PCT/US2010/061563 WO2011087790A1 (en)	2009-12-22	2010-12-21	Triple combination for lowering intraocular pres sure

Publications (1)

Publication Number	Publication Date
IN2012DN06416A true IN2012DN06416A (en)	2015-10-09

Family

ID=43743470

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN6416DEN2012 IN2012DN06416A (en)	2009-12-22	2012-07-20

Country Status (15)

Country	Link
US (1)	US20130116254A1 (en)
CN (1)	CN102695498A (en)
AR (1)	AR079696A1 (en)
BR (1)	BR112012017319A2 (en)
CL (1)	CL2012001736A1 (en)
CO (1)	CO6592061A2 (en)
CR (1)	CR20120360A (en)
EC (1)	ECSP12012033A (en)
GT (1)	GT201200213A (en)
IN (1)	IN2012DN06416A (en)
MX (1)	MX2012007397A (en)
NI (1)	NI201200112A (en)
PE (2)	PE20160904A1 (en)
TW (1)	TW201143773A (en)
WO (1)	WO2011087790A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050244458A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Sustained release intraocular implants and methods for treating ocular neuropathies
CA2807084C (en)	2010-07-29	2018-05-22	Allergan, Inc.	Preservative free brimonidine and timolol solutions
EP2841104A1 (en)	2012-04-24	2015-03-04	Allergan, Inc.	Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
EP3270892B1 (en) *	2015-03-19	2024-04-10	Allergan, Inc.	Fixed dose combination of brimonidine and timolol
US20210121534A1 (en) *	2018-06-19	2021-04-29	Cella Therapeutics, Llc	Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a cnp compound, an npr-b compound, a tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension
US12064440B2 (en) *	2022-03-21	2024-08-20	Somerset Therapeutics, Llc	Ophthalmic gel compositions of bimatoprost and timolol and associated methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4994274A (en)	1989-07-27	1991-02-19	Allergan, Inc.	Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en)	1989-07-27	1991-07-02	Allergan, Inc.	Intraocular pressure reducing 9,15-diacyl prostaglandins
US5034413A (en)	1989-07-27	1991-07-23	Allergan, Inc.	Intraocular pressure reducing 9,11-diacyl prostaglandins
US7030149B2 (en) *	2002-04-19	2006-04-18	Allergan, Inc.	Combination of brimonidine timolol for topical ophthalmic use
US7851504B2 (en) *	2005-03-16	2010-12-14	Allergan, Inc.	Enhanced bimatoprost ophthalmic solution

2010
- 2010-12-21 BR BR112012017319A patent/BR112012017319A2/en not_active Application Discontinuation
- 2010-12-21 PE PE2016000624A patent/PE20160904A1/en unknown
- 2010-12-21 WO PCT/US2010/061563 patent/WO2011087790A1/en active Application Filing
- 2010-12-21 PE PE2012000877A patent/PE20121468A1/en not_active Application Discontinuation
- 2010-12-21 MX MX2012007397A patent/MX2012007397A/en active IP Right Grant
- 2010-12-21 US US13/698,182 patent/US20130116254A1/en not_active Abandoned
- 2010-12-21 CN CN2010800609772A patent/CN102695498A/en active Pending
- 2010-12-22 TW TW099145385A patent/TW201143773A/en unknown
- 2010-12-22 AR ARP100104881A patent/AR079696A1/en not_active Application Discontinuation
2012
- 2012-06-22 CL CL2012001736A patent/CL2012001736A1/en unknown
- 2012-06-22 GT GT201200213A patent/GT201200213A/en unknown
- 2012-06-22 NI NI201200112A patent/NI201200112A/en unknown
- 2012-06-29 CR CR20120360A patent/CR20120360A/en unknown
- 2012-07-11 EC ECSP12012033 patent/ECSP12012033A/en unknown
- 2012-07-19 CO CO12122166A patent/CO6592061A2/en not_active Application Discontinuation
- 2012-07-20 IN IN6416DEN2012 patent/IN2012DN06416A/en unknown

Also Published As

Publication number	Publication date
GT201200213A (en)	2014-08-29
CO6592061A2 (en)	2013-01-02
CN102695498A (en)	2012-09-26
CL2012001736A1 (en)	2012-10-12
WO2011087790A1 (en)	2011-07-21
AR079696A1 (en)	2012-02-15
NI201200112A (en)	2013-04-09
PE20121468A1 (en)	2012-10-28
TW201143773A (en)	2011-12-16
MX2012007397A (en)	2012-08-15
US20130116254A1 (en)	2013-05-09
ECSP12012033A (en)	2012-10-30
PE20160904A1 (en)	2016-09-16
BR112012017319A2 (en)	2016-04-19
CR20120360A (en)	2012-07-30

Publication	Publication Date	Title
BE2015C040I2 (en)	2024-10-08
BRPI0925311A2 (en)	2016-02-02
BR112012003062A2 (en)	2017-05-02
BRPI0924307A2 (en)	2017-08-22
BR112012012396A2 (en)	2021-11-03
BR112012000607A2 (en)	2017-09-05
BR122021004633A2 (en)	2020-10-13
BR112012012487A2 (en)	2021-11-23
BR112012000665A2 (en)	2017-09-05
BR122017024704A2 (en)	2011-02-03
BRPI1013834A2 (en)	2017-08-29
BRPI0924534A2 (en)	2021-12-07
BR122019005883A2 (en)	2019-09-03
BR112012001263A2 (en)	2017-08-15
BR112012000159A2 (en)	2017-08-15
BR112012014856A2 (en)	2021-11-03
BR112012000255A2 (en)	2015-11-03
BRPI0925022A2 (en)	2016-02-02
BR112012000156A2 (en)	2017-08-22
BRPI0924617A2 (en)	2017-07-11
BR122017013721A2 (en)	2011-06-30
BR112012016234A2 (en)	2017-09-12
BR112012000689A2 (en)	2017-09-05
BRPI0925016A2 (en)	2016-02-02
IN2012DN06416A (en)	2015-10-09